Invest with Bioverge
Syndicate Backing
$80.3K ($5K)
Typical Investments
Deals Last 12 Months
Note from Bioverge

Bioverge is an virtual venture capital firm and angel investing platform. We help investors discover, fund, and support the most promising life science and healthcare technology startups.

We seek disruptive companies utilizing advances in technology to modernize healthcare, from bench to bedside. We are proud to have invested in disruptive companies whose technological advancements and personalized medicine vision have the potential to extend life and drastically optimize and expand healthcare treatment options.

Investing in novel science and technology is inherently risky

  • To identify the best opportunities for our community, Bioverge has developed a Dynamic Diligence process and algorithm, which analyzes key investment readiness metrics, opportunity-specific challenges, and input from subject matter experts to evaluate each opportunity on a risk-adjusted basis.

Only the highest quality and transparent opportunities are passed along to our community for evaluation

  • The Bioverge community offers angel investors the chance to review vetted, transparent opportunities to invest alongside seasoned professionals at established investment terms.
  • In addition to our deep screening, investors receive detailed information and tools to individually vet each deal, including opportunities to engage with the company and domain experts within the Bioverge community.

Investors inclined to participate can do so within comfort levels

  • Bioverge provides access with low investment minimums. Investors can choose between single company investments or diversification using Bioverge multi-company funds.

Disrupting healthcare, together

  • The pathway to market for life science and healthcare technologies is unique and often riddled with hurdles. To optimize each company’s trajectory, Bioverge community support extends beyond the deal.
  • Bioverge members are passionate about improving healthcare and have extensive technical/domain expertise, as well as vast industry and later-stage financing connections.
  • Investors and companies alike benefit from a multidisciplinary ecosystem with tools in place to increase engagement, advise, network, and otherwise support community companies.


Invest in the future of healthcare

  • To gain access to our exclusive deal flow automatically, we encourage you to back the @Bioverge syndicate. You can sever your relationship with us at any time, and choose to not invest in any deal for any reason.

Please note: Angel investing in technology startups is risky. There is a meaningful chance that a company will fail and return no money back to investors. Even with a successful company, investors should be prepared to have their capital committed for up to 10 years without liquidity.



We syndicate our deal flow through AngelList when it's appropriate for the founders we are supporting. Our deals are highly curated and must pass the investment process outlined above prior to syndication.

Rick Gibb
Co-founder @Bioverge • Venture Capital @Stanford University • Studied @Johns Hopkins University, @Rice University
Neil Littman
Founder @Bioverge. Investing in the future: bio + tech @Notable Labs @Ligandal @Echo Laboratories @CrowdMed @Blue Mesa Health
Private investments may not be included yet.
All deals on AngelList default to private. Learn More »
Jeremy Levine
Founder/CEO @DRAFT. Investor in 40+ startups.
Sundeep Ahuja
55 Syndicates incl @Mosaic @Good Eggs @Burrow @Starcity; 3yrs @AWS; CoFndr @Richrelevance; Investor @Goodreads; Advisor @Indiegogo; BS CS Stanford
Raj DasGupta
Cloud Computing/SAAS at scale for A&D/Life Sciences Author of The Icarus Prediction 80+ Angel Investments UMBC Alumni Stanford AI Graduate Studies
Ken Keller
Co-founder,, Cadence (SDA); emp #1 excite; emp #2 Frame. All but excite are current leaders.
Tyler Willis
Angel Investor
Founder of @Unsupervised — Investor in @Patreon, @Acre Designs, @Lyft and 40+ other startups.
Can help with
“I've been on the founding team of two startups, and run both marketing and partnerships teams. I tend to be helpful around thinking through marketing or...more
Armando Biondi
Cofounder @AdEspresso, acquired by @Hootsuite in Feb 2017. Investor in 50 startups + @AngelList Lead. Guest Contributor, former Radio Speaker, proud #500strong
Stefano Bernardi
Co-Founder and Partner @Mission and Market Previously co-founded @Kickpay (YC W15) and was at @Betable, @500 Startups and @TechCrunch. BSc Computer Engineering
Rob Ness
Angel Investor
Obsessively hunts the world's fastest-growth startups. Moonlights as strategist @Capgemini. Served time @Harvard, @Berkeley.
Can help with
“I'm very plugged into the rapidly growing tech scene here in Washington DC, and am proactive about promoting the products of my portfolio companies...more
Neil and his new platform Bioverge have been a great resource for myself and Notable Labs. He has an extensive network across life sciences, and pitches in with great input on strategy and troubleshooting. I look forward to every meeting with Neil and think of him as a member of our team!
Neil lead an SPV investment in CrowdMed with Bioverge, and was professional and easy to work with throughout the process. He has a solid understanding of the healthcare ecosystem and asks all the right questions.
I love working with Neil and Rick at Bioverge. From the beginning of their diligence process to completion, they demonstrated a standout understanding of the industry as a whole, as well as our specific technical approach and immediate use cases. Neil has seen a lot of technologies through his...more
Bioverge is one of my top sources of highly-curated biotech and healthtech investment opportunities. Their deal flow, diligence process and syndicate reach make me more comfortable investing in companies they back than many others. Once committed, I have also seen how Bioverge supports its...more
Raise money from value-add investors
One entry on your cap table
$0 Fees · 100% Private
Access to private deals
Invest with experienced angel investors
Over 200 active syndicates